A detailed history of Fmr LLC transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Fmr LLC holds 2,164 shares of SCPH stock, worth $11,209. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,164
Previous 2,977 27.31%
Holding current value
$11,209
Previous $14,000 35.71%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$3.51 - $5.21 $2,853 - $4,235
-813 Reduced 27.31%
2,164 $9,000
Q1 2024

May 13, 2024

SELL
$4.86 - $6.39 $3,737 - $4,913
-769 Reduced 20.53%
2,977 $14,000
Q4 2023

Feb 13, 2024

BUY
$4.7 - $6.63 $14,053 - $19,823
2,990 Added 395.5%
3,746 $23,000
Q3 2023

Nov 13, 2023

SELL
$7.0 - $9.82 $91 - $127
-13 Reduced 1.69%
756 $5,000
Q2 2023

Aug 11, 2023

BUY
$8.94 - $11.74 $482 - $633
54 Added 7.55%
769 $7,000
Q2 2022

Aug 12, 2022

SELL
$4.3 - $6.48 $748 - $1,127
-174 Reduced 19.57%
715 $3,000
Q1 2022

May 13, 2022

BUY
$3.9 - $6.11 $3,467 - $5,431
889 New
889 $5,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $142M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.